Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

0
Player Avatar surabayajhonny (87.58) Submitted: 8/10/2011 5:24:41 PM : Outperform Start Price: $10.14 DNDN Score: -20.19

Jim Mueller

Featured Broker Partners


Advertisement